Literature DB >> 25255770

Activation of PPARδ: from computer modelling to biological effects.

Shirin Kahremany1, Ariela Livne, Arie Gruzman, Hanoch Senderowitz, Shlomo Sasson.   

Abstract

PPARδ is a ligand-activated receptor that dimerizes with another nuclear receptor of the retinoic acid receptor family. The dimers interact with other co-activator proteins and form active complexes that bind to PPAR response elements and promote transcription of genes involved in lipid metabolism. It appears that various natural fatty acids and their metabolites serve as endogenous activators of PPARδ; however, there is no consensus in the literature on the nature of the prime activators of the receptor. In vitro and cell-based assays of PPARδ activation by fatty acids and their derivatives often produce conflicting results. The search for synthetic and selective PPARδ agonists, which may be pharmacologically useful, is intense. Current rational modelling used to obtain such compounds relies mostly on crystal structures of synthetic PPARδ ligands with the recombinant ligand binding domain (LBD) of the receptor. Here, we introduce an original computational prediction model for ligand binding to PPARδ LBD. The model was built based on EC50 data of 16 ligands with available crystal structures and validated by calculating binding probabilities of 82 different natural and synthetic compounds from the literature. These compounds were independently tested in cell-free and cell-based assays for their capacity to bind or activate PPARδ, leading to prediction accuracy of between 70% and 93% (depending on ligand type). This new computational tool could therefore be used in the search for natural and synthetic agonists of the receptor.
© 2014 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25255770      PMCID: PMC4301687          DOI: 10.1111/bph.12950

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  113 in total

1.  Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy.

Authors:  Richard A Friesner; Jay L Banks; Robert B Murphy; Thomas A Halgren; Jasna J Klicic; Daniel T Mainz; Matthew P Repasky; Eric H Knoll; Mee Shelley; Jason K Perry; David E Shaw; Perry Francis; Peter S Shenkin
Journal:  J Med Chem       Date:  2004-03-25       Impact factor: 7.446

2.  Discovery of a novel class of PPARdelta partial agonists.

Authors:  Barry G Shearer; Hari S Patel; Andrew N Billin; James M Way; Deborah A Winegar; Millard H Lambert; Robert X Xu; Lisa M Leesnitzer; Raymond V Merrihew; Stephane Huet; Timothy M Willson
Journal:  Bioorg Med Chem Lett       Date:  2008-08-09       Impact factor: 2.823

3.  Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid.

Authors:  J P Renaud; N Rochel; M Ruff; V Vivat; P Chambon; H Gronemeyer; D Moras
Journal:  Nature       Date:  1995-12-14       Impact factor: 49.962

4.  PPARalpha and PPARdelta activators inhibit cytokine-induced nuclear translocation of NF-kappaB and expression of VCAM-1 in EAhy926 endothelial cells.

Authors:  Yves Rival; Nathalie Benéteau; Thierry Taillandier; Mylène Pezet; Elisabeth Dupont-Passelaigue; Jean François Patoiseau; Didier Junquéro; Francis C Colpaert; André Delhon
Journal:  Eur J Pharmacol       Date:  2002-01-25       Impact factor: 4.432

5.  Structure of the progesterone receptor-deoxyribonucleic acid complex: novel interactions required for binding to half-site response elements.

Authors:  Sarah C Roemer; Douglas C Donham; Lori Sherman; Vickie H Pon; Dean P Edwards; Mair E A Churchill
Journal:  Mol Endocrinol       Date:  2006-08-24

Review 6.  PPARs at the crossroads of lipid signaling and inflammation.

Authors:  Walter Wahli; Liliane Michalik
Journal:  Trends Endocrinol Metab       Date:  2012-06-14       Impact factor: 12.015

7.  Heterodimerization of thyroid hormone (TH) receptor with H-2RIIBP (RXR beta) enhances DNA binding and TH-dependent transcriptional activation.

Authors:  P L Hallenbeck; M S Marks; R E Lippoldt; K Ozato; V M Nikodem
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

8.  Activation of peroxisome proliferator-activated receptor delta induces fatty acid beta-oxidation in skeletal muscle and attenuates metabolic syndrome.

Authors:  Toshiya Tanaka; Joji Yamamoto; Satoshi Iwasaki; Hiroshi Asaba; Hiroki Hamura; Yukio Ikeda; Mitsuhiro Watanabe; Kenta Magoori; Ryoichi X Ioka; Keisuke Tachibana; Yuichiro Watanabe; Yasutoshi Uchiyama; Koichi Sumi; Haruhisa Iguchi; Sadayoshi Ito; Takefumi Doi; Takao Hamakubo; Makoto Naito; Johan Auwerx; Masashi Yanagisawa; Tatsuhiko Kodama; Juro Sakai
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-15       Impact factor: 11.205

9.  Role of PPAR-beta in hydrogen peroxide-induced apoptosis in human umbilical vein endothelial cells.

Authors:  Bimei Jiang; Pengfei Liang; Bing Zhang; Juan Song; Xiaoyuan Huang; Xianzhong Xiao
Journal:  Atherosclerosis       Date:  2008-09-17       Impact factor: 5.162

Review 10.  Structure and physiological functions of the human peroxisome proliferator-activated receptor gamma.

Authors:  Andrzej Zieleniak; Marzena Wójcik; Lucyna A Woźniak
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2008 Sep-Oct       Impact factor: 4.291

View more
  8 in total

1.  PPAR Agonists, Compounds, Pharmaceutical Compositions, and Methods of Use Thereof.

Authors:  Benjamin Blass
Journal:  ACS Med Chem Lett       Date:  2016-08-26       Impact factor: 4.345

Review 2.  Bone muscle crosstalk targets muscle regeneration pathway regulated by core circadian transcriptional repressors DEC1 and DEC2.

Authors:  Jeffrey P Gorski; Jeffrey L Price
Journal:  Bonekey Rep       Date:  2016-11-16

Review 3.  European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS).

Authors:  Javier Egea; Isabel Fabregat; Yves M Frapart; Pietro Ghezzi; Agnes Görlach; Thomas Kietzmann; Kateryna Kubaichuk; Ulla G Knaus; Manuela G Lopez; Gloria Olaso-Gonzalez; Andreas Petry; Rainer Schulz; Jose Vina; Paul Winyard; Kahina Abbas; Opeyemi S Ademowo; Catarina B Afonso; Ioanna Andreadou; Haike Antelmann; Fernando Antunes; Mutay Aslan; Markus M Bachschmid; Rui M Barbosa; Vsevolod Belousov; Carsten Berndt; David Bernlohr; Esther Bertrán; Alberto Bindoli; Serge P Bottari; Paula M Brito; Guia Carrara; Ana I Casas; Afroditi Chatzi; Niki Chondrogianni; Marcus Conrad; Marcus S Cooke; João G Costa; Antonio Cuadrado; Pham My-Chan Dang; Barbara De Smet; Bilge Debelec-Butuner; Irundika H K Dias; Joe Dan Dunn; Amanda J Edson; Mariam El Assar; Jamel El-Benna; Péter Ferdinandy; Ana S Fernandes; Kari E Fladmark; Ulrich Förstermann; Rashid Giniatullin; Zoltán Giricz; Anikó Görbe; Helen Griffiths; Vaclav Hampl; Alina Hanf; Jan Herget; Pablo Hernansanz-Agustín; Melanie Hillion; Jingjing Huang; Serap Ilikay; Pidder Jansen-Dürr; Vincent Jaquet; Jaap A Joles; Balaraman Kalyanaraman; Danylo Kaminskyy; Mahsa Karbaschi; Marina Kleanthous; Lars-Oliver Klotz; Bato Korac; Kemal Sami Korkmaz; Rafal Koziel; Damir Kračun; Karl-Heinz Krause; Vladimír Křen; Thomas Krieg; João Laranjinha; Antigone Lazou; Huige Li; Antonio Martínez-Ruiz; Reiko Matsui; Gethin J McBean; Stuart P Meredith; Joris Messens; Verónica Miguel; Yuliya Mikhed; Irina Milisav; Lidija Milković; Antonio Miranda-Vizuete; Miloš Mojović; María Monsalve; Pierre-Alexis Mouthuy; John Mulvey; Thomas Münzel; Vladimir Muzykantov; Isabel T N Nguyen; Matthias Oelze; Nuno G Oliveira; Carlos M Palmeira; Nikoletta Papaevgeniou; Aleksandra Pavićević; Brandán Pedre; Fabienne Peyrot; Marios Phylactides; Gratiela G Pircalabioru; Andrew R Pitt; Henrik E Poulsen; Ignacio Prieto; Maria Pia Rigobello; Natalia Robledinos-Antón; Leocadio Rodríguez-Mañas; Anabela P Rolo; Francis Rousset; Tatjana Ruskovska; Nuno Saraiva; Shlomo Sasson; Katrin Schröder; Khrystyna Semen; Tamara Seredenina; Anastasia Shakirzyanova; Geoffrey L Smith; Thierry Soldati; Bebiana C Sousa; Corinne M Spickett; Ana Stancic; Marie José Stasia; Holger Steinbrenner; Višnja Stepanić; Sebastian Steven; Kostas Tokatlidis; Erkan Tuncay; Belma Turan; Fulvio Ursini; Jan Vacek; Olga Vajnerova; Kateřina Valentová; Frank Van Breusegem; Lokman Varisli; Elizabeth A Veal; A Suha Yalçın; Olha Yelisyeyeva; Neven Žarković; Martina Zatloukalová; Jacek Zielonka; Rhian M Touyz; Andreas Papapetropoulos; Tilman Grune; Santiago Lamas; Harald H H W Schmidt; Fabio Di Lisa; Andreas Daiber
Journal:  Redox Biol       Date:  2017-05-18       Impact factor: 11.799

4.  Extensive reprogramming of the nascent transcriptome during iPSC to hepatocyte differentiation.

Authors:  Leena E Viiri; Tommi Rantapero; Mostafa Kiamehr; Anna Alexanova; Mikko Oittinen; Keijo Viiri; Henri Niskanen; Matti Nykter; Minna U Kaikkonen; Katriina Aalto-Setälä
Journal:  Sci Rep       Date:  2019-03-05       Impact factor: 4.379

5.  Bavachinin exhibits antitumor activity against non‑small cell lung cancer by targeting PPARγ.

Authors:  Lu-Na Ge; Lei Yan; Cheng Li; Kai Cheng
Journal:  Mol Med Rep       Date:  2019-07-11       Impact factor: 3.423

Review 6.  Review of in silico studies dedicated to the nuclear receptor family: Therapeutic prospects and toxicological concerns.

Authors:  Asma Sellami; Manon Réau; Matthieu Montes; Nathalie Lagarde
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-13       Impact factor: 6.055

7.  Discovering highly selective and diverse PPAR-delta agonists by ligand based machine learning and structural modeling.

Authors:  Benny Da'adoosh; David Marcus; Anwar Rayan; Fred King; Jianwei Che; Amiram Goldblum
Journal:  Sci Rep       Date:  2019-01-31       Impact factor: 4.379

8.  Diet-induced dyslipidemia induces metabolic and migratory adaptations in regulatory T cells.

Authors:  Jacob Amersfoort; Frank H Schaftenaar; Hidde Douna; Peter J van Santbrink; Gijs H M van Puijvelde; Bram Slütter; Amanda C Foks; Amy Harms; Estefania Moreno-Gordaliza; Yanyan Wang; Thomas Hankemeier; Ilze Bot; Hongbo Chi; Johan Kuiper
Journal:  Cardiovasc Res       Date:  2021-04-23       Impact factor: 13.081

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.